Sanibel Captiva Trust Company’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.7M Sell
68,305
-2,691
-4% -$921K 0.62% 43
2026
Q1
$25M Sell
70,996
-1,303
-2% -$465K 0.7% 41
2025
Q4
$23.7M Sell
72,299
-1,229
-2% -$390K 0.65% 40
2025
Q3
$20.7M Sell
73,528
-1,188
-2% -$345K 0.59% 44
2025
Q2
$20.9M Sell
74,716
-3,053
-4% -$865K 0.64% 39
2025
Q1
$24.2M Sell
77,769
-3,123
-4% -$922K 0.79% 35
2024
Q4
$21.1M Buy
80,892
+588
+0.7% +$174K 0.67% 38
2024
Q3
$25.9M Sell
80,304
-634
-0.8% -$207K 0.83% 33
2024
Q2
$25.3M Sell
80,938
-1,868
-2% -$549K 0.87% 30
2024
Q1
$23.5M Sell
82,806
-837
-1% -$245K 0.8% 33
2023
Q4
$24.1M Buy
+83,643
New +$22.8M 0.89% 31

Other funds holding AMGN

Sanibel Captiva Trust Company's AMGN Position: Q2 2026 in Review

Sanibel Captiva Trust Company reduced its Amgen (AMGN) stake by 3.8% in Q2 2026, selling an estimated $921K and leaving 68,305 shares worth $24.7M. The position accounts for 0.62% of the portfolio, ranked #43.

Sanibel Captiva Trust Company first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $25.9M in Q3 2024. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sanibel Captiva Trust Company held 68,305 shares of Amgen worth $24.7M as of Q2 2026.
  • Sanibel Captiva Trust Company sold 2,691 Amgen shares in Q2 2026, an estimated $921K.
  • Amgen made up 0.62% of Sanibel Captiva Trust Company's portfolio in Q2 2026, its #43 holding.
  • Sanibel Captiva Trust Company first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Sanibel Captiva Trust Company's Amgen position peaked at $25.9M in Q3 2024.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sanibel Captiva Trust Company's 13F filing for Q2 2026, filed 27 Jul 2026.